Signals were broadly positive for months, but never definitive: the tocilizumab story

BACKGROUND: Most treatment guidelines for coronavirus disease 2019 (COVID-19) currently recommend tocilizumab in combination with dexamethasone in critically ill patients who are exhibiting rapid respiratory decompensation. AIMS: To produce a critical review and summary of the pathway which led to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cozzi-Lepri, Alessandro, Smith, Colette, Mussini, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576060/
https://www.ncbi.nlm.nih.gov/pubmed/34768021
http://dx.doi.org/10.1016/j.cmi.2021.10.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576060/
https://www.ncbi.nlm.nih.gov/pubmed/34768021
http://dx.doi.org/10.1016/j.cmi.2021.10.018

Ejemplares similares